O
MDT icon

OppenheimerFunds’s Medtronic MDT Stock Holding History

OppenheimerFunds’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,010
Closed -$235K – 1753
2015
Q3 		$235K Buy
+3,010
New +$222K ﹤0.01% 915

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OppenheimerFunds's MDT Position: Q1 2019 in Review

OppenheimerFunds increased its Medtronic (MDT) stake by 97% in Q1 2019, buying an estimated $66.8M and bringing the position to 1,520,155 shares worth $138M. The position accounts for 0.17% of the portfolio, ranked #132.

OppenheimerFunds first reported a position in MDT in Q2 2013 and has held it in 24 quarters since. The position peaked at $258M in Q3 2016. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

  • OppenheimerFunds held 1,520,155 shares of Medtronic worth $138M as of Q1 2019.
  • OppenheimerFunds bought 746,546 Medtronic shares in Q1 2019, an estimated $66.8M.
  • Medtronic made up 0.17% of OppenheimerFunds's portfolio in Q1 2019, its #132 holding.
  • OppenheimerFunds first reported a position in Medtronic in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's Medtronic position peaked at $258M in Q3 2016.
  • 1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.